Benzinga | Jan 22, 2021 06:02AM EST

Cantor Fitzgerald Initiates Coverage On iBio with Overweight Rating, Announces Price Target of $3

Cantor Fitzgerald analyst Kristen Kluska initiates coverage on iBio (AMEX:IBIO) with a Overweight rating and announces Price Target of $3.